Stockreport

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]

Indivior PLC - Ordinary Shares  (INDV) 
PDF GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced [Read more]